Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health concern, especially in developing countries. The burden of this disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which affects not only primary respiratory but also other organ systems, ke...

Full description

Bibliographic Details
Main Authors: Damir Vukoja, Andrea Jurić, Zdravka Erkapić, Tomislav Pejić, Željko Zovko, Josipa Juričić, Jelena Pejić, Matea Ćorluka
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
coronavirus
SARS-CoV-2
dexamethasone
corticosteroids
primary health care
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.684537/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.684537/full

Similar Items